Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
ViroMissile, Inc.
National Cancer Institute (NCI)
University Health Network, Toronto
Guangzhou FineImmune Biotechnology Co., LTD.
GONGCHU Biotechnology Co., Ltd
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Corvus Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
Prelude Therapeutics
Quadriga Biosciences, Inc.
Celgene
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Colorado, Denver
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Shenzhen Second People's Hospital
Memorial Sloan Kettering Cancer Center
Valerio Therapeutics
Valerio Therapeutics
Pfizer
Dartmouth-Hitchcock Medical Center
Memorial Sloan Kettering Cancer Center
Novartis
Emory University
InSightec
National Institutes of Health Clinical Center (CC)
Poniard Pharmaceuticals